You are in a "view as others" mode
Overview
Reinventing Cancer Immunotherapy
Description
Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.
Founded 2016
10-20
Categories
Products
Looks like Valo Therapeutics Ltd has no published products yet.
Services
Looks like Valo Therapeutics Ltd has no published services yet.
Company reviews
Profile Strength:
undefined%
profile
completion